Independent radiologic review of the Gynecologic Oncology Group Study 0218, a phase III trial of bevacizumab in the primary treatment of advanced epithelial ovarian, primary peritoneal, or fallopian tube cancer

Oncology Group ◽

Fallopian Tube Cancer ◽

Phase Iii Trial ◽

Faculty Opinions recommendation of Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.8972962.9534062 ◽

2011 ◽

Author(s):

Lee-May Chen

Keyword(s):

Gynecologic Oncology ◽

Low Risk ◽

Phase Iii ◽

Gestational Trophoblastic Neoplasia ◽

Oncology Group ◽

Phase Iii Trial ◽

Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: A Gynecologic Oncology Group Study

Gynecologic Oncology ◽

10.1016/j.ygyno.2005.11.013 ◽

2006 ◽

Vol 100 (1) ◽

pp. 27-32 ◽

Cited By ~ 227

Author(s):

Joan L. Walker ◽

Deborah K. Armstrong ◽

Helen Q. Huang ◽

Jeffrey Fowler ◽

Kenneth Webster ◽

...

Keyword(s):

Intraperitoneal Chemotherapy ◽

Gynecologic Oncology ◽

Phase Iii ◽

Stage Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Response to Dr. Markman's letter “Re: ‘Randomized phase III trial of three versus six cycles of carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: A Gynecologic Oncology Group Study’”

Gynecologic Oncology ◽

10.1016/j.ygyno.2007.01.007 ◽

2007 ◽

Vol 105 (1) ◽

pp. 280-281

Author(s):

J BELL

Keyword(s):

Ovarian Carcinoma ◽

Early Stage ◽

Gynecologic Oncology ◽

Epithelial Ovarian Carcinoma ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study

The Women s Oncology Review ◽

10.3109/14733400412331312594 ◽

2004 ◽

Vol 4 (3) ◽

pp. 205-207

Keyword(s):

Endometrial Carcinoma ◽

Gynecologic Oncology ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2008.11.014 ◽

2009 ◽

Vol 112 (3) ◽

pp. 543-552 ◽

Cited By ~ 139

Author(s):

Howard D. Homesley ◽

Virginia Filiaci ◽

Susan K. Gibbons ◽

Harry J. Long ◽

David Cella ◽

...

Keyword(s):

Endometrial Carcinoma ◽

Gynecologic Oncology ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

Randomized Phase III Trial of Cisplatin With or Without Topotecan in Carcinoma of the Uterine Cervix: A Gynecologic Oncology Group Study

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70097-6 ◽

2006 ◽

Vol 2006 ◽

pp. 135-137

Author(s):

J.T. Thigpen

Keyword(s):

Uterine Cervix ◽

Gynecologic Oncology ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

Phase III Trial of Doxorubicin With or Without Cisplatin in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

Yearbook of Obstetrics Gynecology and Women s Health ◽

10.1016/s1090-798x(08)70601-5 ◽

2006 ◽

Vol 2006 ◽

pp. 457-458

Author(s):

D.S. Miller

Keyword(s):

Endometrial Carcinoma ◽

Gynecologic Oncology ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

Faculty Opinions recommendation of Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1102319.558354 ◽

2008 ◽

Author(s):

Paola Gehrig

Keyword(s):

Endometrial Cancer ◽

High Risk ◽

Gynecologic Oncology ◽

Phase Iii ◽

Combined Chemotherapy ◽

Oncology Group ◽

Pelvic Radiotherapy ◽

Phase Iii Trial ◽

Faculty Opinions recommendation of A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1158196.617794 ◽

2009 ◽

Author(s):

Enrico Sartori

Keyword(s):

Endometrial Carcinoma ◽

Gynecologic Oncology ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

Faculty Opinions recommendation of A randomized phase III trial of IV carboplatin and paclitaxel × 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinoma: a Gynecologic Oncology Group Study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.12184956.13346054 ◽

2011 ◽

Author(s):

Ashley Stuckey

Keyword(s):

Ovarian Carcinoma ◽

Low Dose ◽

Early Stage ◽

Gynecologic Oncology ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽